Open index

Health

Confirmed cases of RR-/MDR-TB

Gap rank 26. Open quest. The company search finished and found none.

Demand
46
Supply
40
Gap
6
Companies
0

Headline: 173,308 cases in 2024. Retrieved 2026-11-10. This is not a valuation.

Sourced numbers

Known companies

Names come from the OpenAlex company search and, when the list fits on one page, ClinicalTrials.gov industry lead sponsors. The same company can appear in both. Placeholders are not listed here and are not counted.

No named company link was returned for this search.

AI-generated suggestion. Not a real company. Not a forecast.

Acme Confirmed cases of RR-/MDR-TB Co. (open quest, not a real company)

This placeholder is not counted as supply. It has no revenue, funding, or valuation.

Founder starter pack

A company whose job is Confirmed cases of RR-/MDR-TB, and whose progress report is the sourced figure of 173,308 cases in 2024.

Customer: The people counted in the headline metric, and the payer that already spends money when the condition gets worse.

First product: one measured pilot in one health system. Pick the headline metric, pick one site, and see if that sourced number moves.

Metrics to move

Key papers

Most-cited OpenAlex articles returned for a short title search on this problem. A neighboring topic can still appear. This is not a curated reading list.

  1. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis · 2010 · 1,050 citations in OpenAlex
  2. An Outbreak of Multidrug-Resistant Tuberculosis among Hospitalized Patients with the Acquired Immunodeficiency Syndrome · 1992 · 843 citations in OpenAlex
  3. The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis · 2009 · 841 citations in OpenAlex
  4. Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline · 2014 · 758 citations in OpenAlex
  5. Delamanid for Multidrug-Resistant Pulmonary Tuberculosis · 2012 · 758 citations in OpenAlex
  6. Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study · 2019 · 754 citations in OpenAlex
  7. Short, Highly Effective, and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis · 2010 · 659 citations in OpenAlex
  8. Global Incidence of Multidrug‐Resistant Tuberculosis · 2006 · 527 citations in OpenAlex

Datasets

Funders and grant programs

Comparable companies

No comparable company was sourced.